Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer
FEMS Microbiology Reviews · 05.07.2023 · 47 (4)
DOI: 10.1093/femsre/fuad036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEMS Microbiology Reviews, online erschienen am 05.07.2023. Verfasst von Hao Su und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key laboratory of Digestive Disease, Li Ka Shing Institute of Healt…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 166 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health and Medical Research Fund, Chinese University of Hong Kong.
Abstract (Originalsprache)
The gut microbiota plays a crucial role in regulating various host metabolic, immune, and neuroendocrine functions, and has a significant impact on human health. Several lines of evidence suggest that gut dysbiosis is associated with a variety of diseases, including cancer. The gut microbiota can impact the development and progression of cancer through a range of mechanisms, such as regulating cell proliferation and death, modulating the host immune response, and altering the host metabolic state. Gene regulatory programs are considered critical mediators between the gut microbiota and host phenotype, of which RNA N6-methyladenosine (m6A) modifications have attracted much attention recently. Aberrant m6A modifications have been shown to play a crucial role in cancer development. This review aims to provide an overview of the diverse roles of gut microbiota and RNA m6A modifications in cancer and highlight their potential interactions in cancer development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University o…
- Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong 99077, China.
- School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong 99077, China.
ORCID-Profile: Hao Su, Huarong Chen
Förderung
- National Natural Science Foundation of China
- Health and Medical Research Fund
- Chinese University of Hong Kong
Zitieren
APA
Su, H., Cheung, H., Lau, H. C., Chen, H., Zhang, X., Qin, N., Wang, Y., Chan, M. T. V., Wu, W. K. K., & Chen, H. (2023). Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer. FEMS Microbiology Reviews, 47(4). https://doi.org/10.1093/femsre/fuad036
Vancouver
Su H, Cheung H, Lau HC, Chen H, Zhang X, Qin N, et al. Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer. FEMS Microbiology Reviews. 2023;47(4). doi:10.1093/femsre/fuad036
BibTeX
@article{Su2023,
author = {Su, Hao and Cheung, Henley and Lau, Harry Cheuk-Hay and Chen, Hongyan and Zhang, Xiaoting and Qin, Na and Wang, Yifei and Chan, Matthew Tak Vai and Wu, William Ka Kei and Chen, Huarong},
title = {Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer},
journal = {FEMS Microbiology Reviews},
year = {2023},
volume = {47},
number = {4},
doi = {10.1093/femsre/fuad036}
}
EUVIMED